Nancy A Simonian's Net Worth
$16.6 Million
Who is Nancy A Simonian?
Nancy A Simonian has an estimated net worth of $16.6 Million. This is based on reported shares across multiple companies, which include SEATTLE GENETICS INC /WA, Syros Pharmaceuticals, Inc., Evelo Biosciences, Inc., ARQULE INC, and MILLENNIUM PHARMACEUTICALS INC.
SEC CIK
Nancy A Simonian's CIK is 0001359574
Past Insider Trading and Trends
2018 was Nancy A Simonian's most active year for acquiring shares with 9 total transactions. Nancy A Simonian's most active month to acquire stocks was the month of April. 2008 was Nancy A Simonian's most active year for disposing of shares, totalling 24 transactions. Nancy A Simonian's most active month to dispose stocks was the month of November. 2007 saw Nancy A Simonian paying a total of $895,355.42 for 120,834 shares, this is the most they've acquired in one year. In 2023 Nancy A Simonian cashed out on 302,110 shares for a total of $14,404,965.38, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
SEATTLE GENETICS INC /WA (SGEN) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -62.75K |
$229.00 | -$14,370,437.00 |
0
|
Dec 14
| |||
Form 4
| +3.26% | 2.04K |
—
|
—
| 64.8K |
May 31
| |||
Form 4
| +16.20% | 8.75K |
$36.70 | $321,125.00 | 62.75K |
Dec 12
| |||
Form 4
| +2.86% | 1.5K |
—
|
—
| 54K |
May 13
| |||
Form 4
| +90.91% | 25K |
$20.04 | $501,000.00 | 52.5K |
Mar 2
| |||
Form 4
| +5.37% | 1.4K |
—
|
—
| 27.5K |
May 14
| |||
Form 4
| +5.39% | 1.33K |
—
|
—
| 26.1K |
May 15
| |||
Form 4
| +13.59% | 2.96K |
—
|
—
| 24.76K |
May 20
| |||
Form 4
| +20.44% | 3.7K |
—
|
—
| 21.8K |
May 18
| |||
Form 4
| +25.69% | 3.7K |
—
|
—
| 18.1K |
May 19
| |||
Form 4
| +34.58% | 3.7K |
—
|
—
| 14.4K |
May 20
| |||
Form 4
| +52.86% | 3.7K |
—
|
—
| 10.7K |
May 15
| |||
Form 4
| +100.00% | 3.5K |
—
|
—
| 7K |
May 16
| |||
Form 4
|
∞
| 3.5K |
—
|
—
| 3.5K |
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Syros Pharmaceuticals, Inc. (SYRS) Snapshot price: $1.6
President & CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +29.58% | 40.13K |
—
|
—
| 175.78K |
Oct 31
| |||
Form 4
| +3.04% | 4K |
—
|
—
| 135.66K |
Jun 5
| |||
Form 4
| +31.47% | 31.51K |
$5.12 | -$71,946.24 | 131.66K |
Mar 31 - Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 1
| |||
Form 4
| +36.40% | 26.72K |
$2.22 | -$29,750.22 | 100.14K |
Oct 31 - Nov 1
| |||
Form 4
| +5.99% | 4.15K |
$2.58 | -$4,778.16 | 73.42K |
Mar 31 - Apr 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 6
| |||
Form 4
| -7.83% | -58.88K |
$1.12 | -$65,948.96 | 692.72K |
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 17
| |||
Form 4
| +5.61% | 29.92K |
$6.81 | $203,612.04 | 563.61K |
Dec 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 4
| +10.89% | 52.4K |
$3.04 | $159,299.04 | 533.69K |
Dec 23
| |||
Form 4
| +39.06% | 188K |
—
|
—
| 669.29K |
Feb 12
| |||
Form 4
| +29.83% | 110.59K |
$1.23 | $136,224.40 | 481.29K |
Nov 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 16
| |||
Form 4
| +21.93% | 66.67K |
—
|
—
| 370.7K |
Jul 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Evelo Biosciences, Inc. (EVLO) Snapshot price: $0.05
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ARQULE INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MILLENNIUM PHARMACEUTICALS INC No price found
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -77.41K |
$25.00 | -$1,935,250.00 |
0
|
May 14
| |||
Form 4
| -2.68% | -2.13K |
$24.88 | -$53,069.04 | 77.41K |
Scheduled
|
May 1
| ||
Form 4
| -18.91% | -17.54K |
$13.35 | -$234,173.07 | 75.23K |
Scheduled
|
Mar 5 - Mar 6
| ||
Form 4
| -5.11% | -5.00K |
$13.87 | -$69,367.80 | 92.78K |
Scheduled
|
Feb 29 - Mar 3
| ||
Form 4
| +46.29% | 30.94K |
—
|
—
| 97.78K |
Feb 14
| |||
Form 4
| -3.23% | -2.23K |
$11.76 | -$850,414.11 | 66.84K |
Dec 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||